Current Ratio
since 2005
Calculation
Illumina Inc., current ratio, long-term trends, calculation
| Current ratio | = | Current assets1 | ÷ | Current liabilities1 | |
|---|---|---|---|---|---|
| Dec 31, 2020 | 3.60 | = | 4,483) | ÷ | 1,244) |
| Dec 29, 2019 | 6.69 | = | 4,451) | ÷ | 665) |
| Dec 30, 2018 | 2.49 | = | 4,490) | ÷ | 1,804) |
| Dec 31, 2017 | 3.99 | = | 2,980) | ÷ | 746) |
| Jan 1, 2017 | 3.29 | = | 2,318) | ÷ | 705) |
| Jan 3, 2016 | 3.43 | = | 2,097) | ÷ | 610) |
| Dec 28, 2014 | 2.62 | = | 1,890) | ÷ | 722) |
| Dec 29, 2013 | 5.02 | = | 1,618) | ÷ | 322) |
| Dec 30, 2012 | 5.87 | = | 1,787) | ÷ | 305) |
| Jan 1, 2012 | 6.50 | = | 1,545) | ÷ | 238) |
| Jan 2, 2011 | 2.35 | = | 1,258) | ÷ | 535) |
| Jan 3, 2010 | 2.22 | = | 982) | ÷ | 441) |
| Dec 28, 2008 | 1.70 | = | 865) | ÷ | 510) |
| Dec 30, 2007 | 3.40 | = | 563) | ÷ | 166) |
| Dec 31, 2006 | 5.74 | = | 194) | ÷ | 34) |
| Jan 1, 2006 | 3.67 | = | 80) | ÷ | 22) |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
1 US$ in millions
The company demonstrated a substantial expansion of its short-term financial position between 2006 and 2020. While both current assets and current liabilities grew in absolute terms, the growth in assets was more consistent, maintaining a robust liquidity profile throughout the period analyzed.
- Asset Growth Trends
- Current assets exhibited a steady and significant upward trajectory, increasing from 80 million US dollars in early 2006 to 4,483 million US dollars by the end of 2020. This represents a consistent accumulation of liquid resources over the fifteen-year duration.
- Liability Volatility
- Current liabilities showed more irregular fluctuations compared to the steady growth of assets. Notable spikes occurred in 2008, 2014, and 2018, with the latter reaching a peak of 1,804 million US dollars. These periods of increased liabilities coincided with temporary contractions in the overall current ratio.
- Liquidity and Solvency Analysis
- The current ratio remained consistently above 1.0 throughout the entire period, indicating that short-term obligations were always well-covered by current assets. Significant liquidity peaks were observed in 2012 (6.50) and 2019 (6.69), while the lowest liquidity point occurred in 2008 (1.70). The period concluded with a current ratio of 3.60 in 2020, suggesting a strong and stable solvency position.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Comparison to Competitors
Illumina Inc., current ratio, long-term trends, comparison to competitors
| Illumina Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2020 | 3.60 | 0.84 | 1.81 | 1.58 | 1.86 | 1.40 | 1.40 | 1.21 | 1.02 | 1.35 | 3.63 | 2.13 | 4.33 |
| Dec 29, 2019 | 6.69 | 3.18 | 1.44 | 1.60 | 5.19 | 1.16 | 3.10 | 1.26 | 1.24 | 0.88 | 3.67 | 1.92 | 3.61 |
| Dec 30, 2018 | 2.49 | 0.98 | 2.79 | 1.61 | 1.47 | 1.73 | 3.38 | 1.47 | 1.17 | 1.57 | 4.47 | 1.73 | 3.43 |
| Dec 31, 2017 | 3.99 | 1.28 | 5.49 | 1.55 | 1.43 | 1.32 | 2.74 | 1.41 | 1.33 | 1.35 | 3.82 | 1.34 | 3.28 |
| Jan 1, 2017 | 3.29 | 1.65 | 4.11 | 1.55 | 0.97 | 1.37 | 2.22 | 2.47 | 1.78 | 1.25 | 2.56 | 1.44 | 2.31 |
| Jan 3, 2016 | 3.43 | 1.50 | 4.44 | 1.30 | 1.27 | 1.53 | 2.50 | 2.17 | 1.55 | 1.49 | 3.59 | 1.38 | 2.78 |
| Dec 28, 2014 | 2.62 | 1.41 | 4.95 | 1.73 | 1.75 | 1.09 | 3.07 | 2.36 | 1.77 | 2.67 | 3.31 | 1.22 | 4.20 |
| Dec 29, 2013 | 5.02 | 2.59 | 3.44 | 1.52 | 2.01 | 1.47 | 1.15 | 2.20 | 2.00 | 2.41 | 6.01 | 3.16 | 3.99 |
| Dec 30, 2012 | 5.87 | 2.27 | 3.81 | 1.15 | 1.80 | 1.55 | 1.44 | 1.90 | 1.90 | 2.15 | 7.37 | 2.31 | 3.67 |
| Jan 1, 2012 | 6.50 | — | 4.80 | 1.97 | 1.50 | 1.60 | 5.53 | 2.38 | 2.04 | 2.06 | 4.40 | 1.55 | 3.39 |
| Jan 2, 2011 | 2.35 | — | 3.52 | 1.97 | 1.73 | 2.09 | 2.32 | 2.05 | 1.86 | 2.11 | 3.28 | 2.42 | 2.23 |
| Jan 3, 2010 | 2.22 | — | 4.89 | 2.21 | 1.89 | 1.90 | 2.57 | 1.82 | 1.80 | 1.66 | 4.55 | 2.76 | 4.59 |
| Dec 28, 2008 | 1.70 | — | 3.12 | 2.20 | 1.53 | 0.95 | 3.52 | 1.65 | 1.35 | 1.59 | 6.23 | 2.82 | 4.01 |
| Dec 30, 2007 | 3.40 | — | 2.11 | 1.20 | 1.40 | 2.33 | 4.11 | 1.51 | 1.23 | 2.15 | 2.81 | 1.93 | 2.49 |
| Dec 31, 2006 | 5.74 | — | 1.67 | 1.59 | 1.38 | 1.91 | 3.18 | 1.20 | 1.20 | 2.20 | 10.44 | 1.70 | 3.07 |
| Jan 1, 2006 | 3.67 | — | 2.57 | 1.78 | 1.30 | 1.89 | 6.79 | 2.48 | 1.58 | 1.47 | 8.46 | 1.71 | 3.84 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Illumina Inc., current ratio, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Illumina Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Dec 31, 2020 | 3.60 | 1.37 |
| Dec 29, 2019 | 6.69 | 1.66 |
| Dec 30, 2018 | 2.49 | 1.71 |
| Dec 31, 2017 | 3.99 | 1.74 |
| Jan 1, 2017 | 3.29 | 1.91 |
| Jan 3, 2016 | 3.43 | 1.90 |
| Dec 28, 2014 | 2.62 | 2.19 |
| Dec 29, 2013 | 5.02 | 2.17 |
| Dec 30, 2012 | 5.87 | 2.04 |
| Jan 1, 2012 | 6.50 | 2.30 |
| Jan 2, 2011 | 2.35 | 2.14 |
| Jan 3, 2010 | 2.22 | 1.95 |
| Dec 28, 2008 | 1.70 | 1.66 |
| Dec 30, 2007 | 3.40 | 1.74 |
| Dec 31, 2006 | 5.74 | 1.65 |
| Jan 1, 2006 | 3.67 | 1.82 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
Comparison to Industry (Health Care)
Illumina Inc., current ratio, long-term trends, comparison to industry (health care)
| Illumina Inc. | Health Care | |
|---|---|---|
| Dec 31, 2020 | 3.60 | 1.30 |
| Dec 29, 2019 | 6.69 | 1.48 |
| Dec 30, 2018 | 2.49 | 1.52 |
| Dec 31, 2017 | 3.99 | 1.55 |
| Jan 1, 2017 | 3.29 | 1.73 |
| Jan 3, 2016 | 3.43 | 1.70 |
| Dec 28, 2014 | 2.62 | 1.92 |
| Dec 29, 2013 | 5.02 | 1.96 |
| Dec 30, 2012 | 5.87 | 1.84 |
| Jan 1, 2012 | 6.50 | 1.94 |
| Jan 2, 2011 | 2.35 | 1.81 |
| Jan 3, 2010 | 2.22 | 1.78 |
| Dec 28, 2008 | 1.70 | 1.44 |
| Dec 30, 2007 | 3.40 | 1.53 |
| Dec 31, 2006 | 5.74 | 1.39 |
| Jan 1, 2006 | 3.67 | 1.63 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).